Xeris Biopharma Holdings Inc (XERS)
Net Income Growth
-1513.12%
Quarterly · Period ending:
XERS Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-1513.12%period ending
Latest reported-1513.12%period ending
XERS Quarterly Net Income YoY % (-156.12% → -1513.12%)
Year-over-year change
High-resolution chart · PNG
XERS net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -1,513.1224% | |
| 124.2299% | |
| 316.7221% | |
| 103.9459% | |
| 87.1509% | |
| 51.4226% | |
| 61.8148% | |
| -29.1164% | |
| 24.3776% | |
| -12.748% | |
| -3.5576% | |
| 44.1666% | |
| 24.2238% | |
| 50.0682% | |
| 74.5422% | |
| 16.0637% | |
| 4.8337% | |
| -83.1188% | |
| -132.3741% | |
| -62.5563% | |
| -14.1749% | |
| 36.9141% | |
| 33.9308% | |
| 51.273% | |
| 29.9142% | |
| -15.4567% | |
| -62.0158% | |
| -122.3607% | |
| -164.7648% | |
| -112.2869% | |
| -123.2561% | |
| -96.1871% | |
| -148.2225% | |
| -156.1196% |